105 related articles for article (PubMed ID: 40433)
1. Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways.
Gleichmann E; van Elven F; Gleichmann H
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):708-23. PubMed ID: 40433
[TBL] [Abstract][Full Text] [Related]
2. T lymphocytes mediate lymphadenopathy and autoimmunization in graft-versus host reactions and hypersensitivity to diphenylhydantoin.
Gleichmann HI
Agressologie; 1982 Jan; 23(A):53-5. PubMed ID: 6979267
[No Abstract] [Full Text] [Related]
3. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
Solnik C; Gleichmann H; Kavanah M; Schwartz RS
Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
[No Abstract] [Full Text] [Related]
4. Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin.
Tsung SH; Lin JI
Ann Clin Lab Sci; 1981; 11(6):542-5. PubMed ID: 6976773
[TBL] [Abstract][Full Text] [Related]
5. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. IV. Autoantibodies to nuclear antigens.
Van der Veen F; Rolink AG; Gleichmann E
Clin Exp Immunol; 1981 Dec; 46(3):589-96. PubMed ID: 6978221
[TBL] [Abstract][Full Text] [Related]
6. Amyloidosis in immunoblastic lymphadenopathy.
Plavnick L; Weiner P; Pevzner S; Lichtig C
Isr J Med Sci; 1980 Aug; 16(8):599-603. PubMed ID: 6968307
[TBL] [Abstract][Full Text] [Related]
7. [Angio-immunoblastic lymphadenopathy (author's transl)].
Münch O
Arch Geschwulstforsch; 1980; 50(1):46-52. PubMed ID: 7447630
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
[TBL] [Abstract][Full Text] [Related]
9. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted.
Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cheek RL; Cohen PL; Eisenberg RA
J Immunol; 1994 Jun; 152(12):6011-6. PubMed ID: 8207226
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
11. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
12. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. V. High titers of IgG autoantibodies to double-stranded DNA.
van Elven EH; van der Veen FM; Rolink AG; Issa P; Duin TM; Gleichmann E
J Immunol; 1981 Dec; 127(6):2435-8. PubMed ID: 6975323
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
[TBL] [Abstract][Full Text] [Related]
14. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes.
van der Veen JP; Rolink AG; Gleichmann E
J Immunol; 1981 Oct; 127(4):1281-6. PubMed ID: 6974187
[No Abstract] [Full Text] [Related]
15. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
Piguet PF
J Immunol; 1985 Sep; 135(3):1637-43. PubMed ID: 2410497
[TBL] [Abstract][Full Text] [Related]
16. [History and clinical picture of lymphogranulomatosis X (including (angio)immunoblastic lymphadenopathy].
Knecht H; Lennert K
Schweiz Med Wochenschr; 1981 Jul; 111(30):1108-21. PubMed ID: 7268365
[TBL] [Abstract][Full Text] [Related]
17. Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.
van Rappard-van der Veen FM; Rolink AG; Gleichmann E
J Exp Med; 1982 May; 155(5):1555-60. PubMed ID: 6978376
[TBL] [Abstract][Full Text] [Related]
18. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis.
Rolink AG; Gleichmann H; Gleichmann E
J Immunol; 1983 Jan; 130(1):209-15. PubMed ID: 6183348
[No Abstract] [Full Text] [Related]
19. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.
Mountz JD; Gause WC; Finkelman FD; Steinberg AD
J Immunol; 1988 May; 140(9):2943-9. PubMed ID: 2834447
[TBL] [Abstract][Full Text] [Related]
20. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E
J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
